Search

Brian R. Stanton

Examiner (ID: 553)

Most Active Art Unit
1632
Art Unit(s)
1819, 1632, 1621, 1804, 1600
Total Applications
312
Issued Applications
94
Pending Applications
102
Abandoned Applications
115

Applications

Application numberTitle of the applicationFiling DateStatus
08/205720 TERMINAL COMPLEMENT INHIBITOR FUSION GENES AND PROTEINS Mar 2, 1994 Abandoned
Array ( [id] => 3651777 [patent_doc_number] => 05639940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Production of fibrinogen in transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/206176 [patent_app_country] => US [patent_app_date] => 1994-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12833 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639940.pdf [firstpage_image] =>[orig_patent_app_number] => 206176 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/206176
Production of fibrinogen in transgenic animals Mar 2, 1994 Issued
Array ( [id] => 3416277 [patent_doc_number] => 05453363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-26 [patent_title] => 'Process for the activation of t-PA or Ing after genetic expression in prokaryotes' [patent_app_type] => 1 [patent_app_number] => 8/206044 [patent_app_country] => US [patent_app_date] => 1994-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8781 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/453/05453363.pdf [firstpage_image] =>[orig_patent_app_number] => 206044 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/206044
Process for the activation of t-PA or Ing after genetic expression in prokaryotes Mar 1, 1994 Issued
Array ( [id] => 3795924 [patent_doc_number] => 05827683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Nucleic acids encoding BSSL variants' [patent_app_type] => 1 [patent_app_number] => 8/204691 [patent_app_country] => US [patent_app_date] => 1994-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 14707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827683.pdf [firstpage_image] =>[orig_patent_app_number] => 204691 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/204691
Nucleic acids encoding BSSL variants Feb 28, 1994 Issued
08/202755 TRANSGENIC ANIMAL ASSAY SYSTEM FOR ANTICHOLINESTERASE SUBSTANCES Feb 27, 1994 Abandoned
08/201707 PRODUCTION OF ANTIGENS BY SELF-ASSEMBLY OF POLYPEPTIDE COMPONENTS Feb 24, 1994 Abandoned
08/198068 TRANSGENIC FIBRINOGEN Feb 17, 1994 Abandoned
Array ( [id] => 3871597 [patent_doc_number] => 05763416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Gene transfer into bone cells and tissues' [patent_app_type] => 1 [patent_app_number] => 8/199780 [patent_app_country] => US [patent_app_date] => 1994-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 27243 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763416.pdf [firstpage_image] =>[orig_patent_app_number] => 199780 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/199780
Gene transfer into bone cells and tissues Feb 17, 1994 Issued
08/194847 HOMOGENEOUS MAMMALIAN HEMATOPOIETIC STEM CELL COMPOSITION Feb 13, 1994 Abandoned
Array ( [id] => 3441386 [patent_doc_number] => 05466586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-14 [patent_title] => 'Method for the synthesis of ribonucleic acid (RNA)' [patent_app_type] => 1 [patent_app_number] => 8/192756 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2062 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/466/05466586.pdf [firstpage_image] =>[orig_patent_app_number] => 192756 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/192756
Method for the synthesis of ribonucleic acid (RNA) Feb 6, 1994 Issued
08/184260 METHOD OF TARGETING DNA INSERTION INTO GENOME Jan 17, 1994 Abandoned
Array ( [id] => 3660366 [patent_doc_number] => 05667839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Human recombinant collagen in the milk of transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/183648 [patent_app_country] => US [patent_app_date] => 1994-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5519 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667839.pdf [firstpage_image] =>[orig_patent_app_number] => 183648 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/183648
Human recombinant collagen in the milk of transgenic animals Jan 17, 1994 Issued
08/150011 DEFECTIVE RECOMBINANT ADENOVIRUSES EXPRESSING CYTOKINES FOR ANTITUMOR TREATMENT Jan 12, 1994 Abandoned
08/179922 METHOD FOR DETECTING, IDENTIFYING, AND QUANTITATING ORGANISMS AND VIRUSES Jan 10, 1994 Abandoned
08/171184 DIAGNOSIS OF FUNGAL INFECTIONS WITH A CHITINASE Dec 20, 1993 Abandoned
08/170156 METHODS FOR THE PRODUCTION AND USE OF ANTI-IDIOTYPIC ANTIBODIES USING HUMAN IG EXPRESSING TRANSGENIC ANIMALS Dec 19, 1993 Abandoned
Array ( [id] => 3549103 [patent_doc_number] => 05571710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'CDNA coding for carcinoembryonic antigen' [patent_app_type] => 1 [patent_app_number] => 8/170134 [patent_app_country] => US [patent_app_date] => 1993-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10944 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571710.pdf [firstpage_image] =>[orig_patent_app_number] => 170134 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/170134
CDNA coding for carcinoembryonic antigen Dec 19, 1993 Issued
08/169830 UNGULATE PREBLASTOCYST DERIVED EMBRYONIC STEM CELLS AND USE THEREOF TO PRODUCE CLONED TRANSGENIC AND CHIMERIC UNGULATES Dec 16, 1993 Abandoned
08/167642 SYSTEMIC GENE TREATMENT OF CONNECTIVE TISSUE DISEASES Dec 13, 1993 Abandoned
08/162840 METHOD AND AGENTS FOR REMOVING ADVANCED GLYCOSYLATION ENDPRODUCTS Dec 2, 1993 Abandoned
Menu